Healthcare Leaders Hub

🏠Home 📰News 📝Blog 🎬Videos Advertise Login

Your trusted source for pharmaceutical news, expert insights, and healthcare innovation.

💼𝕏 👥▶️

Content

📰News
📝Blog
🎬Videos

Company

🏠Home
🏢About Us
📧Contact

© 2026 PharmaVoice. All rights reserved. Empowering healthcare leaders.

Privacy Policy•Terms of Service

Zydus recalls anti-inflammatory drug in US after impurity test failure | PharmaVoice

ET Pharma

Zydus recalls anti-inflammatory drug in US after impurity test failure

Oct 22, 2026, 6:26 AM

Read Full Article →

Translate article text

Choose a language and wait for the translated text.

According to the US FDA latest enforcement report, Zydus has recalled 70776 vials , manufactured at the company’s Vadodara-based facility in India.